PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

June 30, 2020

Conditions
Bacterial Infections
Interventions
DRUG

Clindamycin

"Route of administration is IV for all Cohorts. Dosing interval is every 8 hrs. for all Cohorts:~* Cohort 1; No. Subjects = 5; Age 1-5 months; Dose = 9 mg/kg;~* Cohort 2; No. Subjects = 5; Age \>5 months to 1 year; Dose =12 mg/kg;~* Cohort 3; No. Subjects = 5; Age \>1-2 years; Dose =12 mg/kg.~* Cohort 4; No. Subjects = 4; Age \>2-6 years; Dose =12 mg/kg.~* Cohort 5; No. Subjects = 4; Age \>6-12 years; Dose =10 mg/kg.~* Cohort 6; No. Subjects = 4; Age \>12-16 years; Dose =10 mg/kg."

DRUG

trimethoprim-sulfamethoxazole

"Route of administration is PO for all Cohorts. Dosing interval is every 12 hrs. for all Cohorts:~* Cohort 1; No. Subjects = 5; Age 1-5 months; Dose = 6 mg/kg.~* Cohort 2; No. Subjects = 5; Age \>5 months to 1 year; Dose = 6 mg/kg.~* Cohort 3; No. Subjects = 5; Age \>1-2 years; Dose = 6 mg/kg.~* Cohort 4; No. Subjects = 4; Age \>2-6 years; Dose = 6 mg/kg.~* Cohort 5; No. Subjects = 4; Age \>6-12 years; Dose = 6 mg/kg.~* Cohort 6; No. Subjects = 4; Age \>12-16 years; Dose = 4 mg/kg."

Trial Locations (3)

48109

University of Michigan C.S. Mott Children's Hospital, Ann Arbor

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

72202

Arkansas Children's Hospital, Little Rock

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Michael Cohen-Wolkowiez

OTHER

NCT02475876 - PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children | Biotech Hunter | Biotech Hunter